The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

E-ISSN： 1873-5576|6|8|671-679

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.8, 2006-01, pp. : 671-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 537-548

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib

By Derenzini Enrico

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 775-785

Informa Healthcare

Access to resources Recommend Favorite

Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 71-77

Bentham Science Publishers

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M Chiarini Francesca Evangelisti Camilla Ognibene Andrea Bressanin Daniela Billi Anna Maria Manzoli Lucia Cappellini Alessandra McCubrey James A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite